Andrew Rees - 04 Aug 2026 Form 4 Insider Report for Crocs, Inc. (CROX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Aug 2026, 18:35:31 UTC
Prior SEC filing
09 Jun 2026
Next SEC filing
11 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Sara Hoverstock, Attorney-in-Fact

Key filing fact

Andrew Rees filed Form 4 for Crocs, Inc. (CROX) on 06 Aug 2026.

Key facts

  • This page summarizes Andrew Rees's Form 4 filing for Crocs, Inc. (CROX).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 06 Aug 2026, 18:35.

Change

  • Previous filing in this sequence was filed on 09 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001609901 Primary reporting owner

Rees Andrew

Relationship
Chief Executive Officer, Director
Address
C/O CROCS, INC., 500 ELDORADO BLVD #5, BROOMFIELD
Signature
/s/Sara Hoverstock, Attorney-in-Fact
Signature date
06 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CROX transaction

Common Stock

Options Exercise

Transaction value
Shares
+200,000
Change %
+42%
Price
$6.98*
Shares after
675,789
Date
04 Aug 2026
Ownership
Direct
CROX transaction

Common Stock

Tax liability

Transaction value
Shares
-105,610
Change %
-16%
Price
$141.19*
Shares after
570,179
Date
04 Aug 2026
Ownership
Direct
Footnotes
F1
CROX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
743,293
Date
04 Aug 2026
Ownership
By Trust
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CROX transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-200,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
04 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
200,000
Exercise price
$6.98
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents shares withheld by the issuer to cover the exercise price and tax withholding obligations upon exercise of employee stock options.

Footnote F2

The reporting person is a trustee of the REES FAMILY LIVING TRUST U/A DTD 03/22/2019 and exercises voting and investment power for the shares beneficially owned by the trust.

Footnote F3

The stock option vested in three tranches: 66,667 shares on June 1, 2018, 66,667 shares on June 1, 2019, and 66,666 shares on June 1, 2020.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .